Editorial Board Members’ Collection Series: Treatment of Pediatric Solid Tumors
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Pediatric Oncology".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 4396
Special Issue Editors
Interests: pediatric melanoma; soft tissue sarcomas; pediatric gastrointestinal stromal tumors
Special Issue Information
Dear Colleagues,
Although rare, pediatric cancers represent the leading cause of death by disease among children. Among them, solid tumors are a heterogeneous group and account for more than 60% of all pediatric malignant neoplasms. Other than brain tumors, the common types of pediatric solid tumors are soft tissue sarcomas, osteosarcoma, neuroblastoma, Wilms tumor, Ewing sarcoma, germ cell tumors, etc. The standard treatment of pediatric solid tumors has included surgical resection, radiation, chemotherapy, and, in recent years immunotherapy and targeted therapy. The spectrum of pediatric solid tumors and their respective prognosis differ significantly and are very different from adult cancers. Therefore, the management of pediatric solid tumors remains a significant challenge, and there is a pressing need for the development of novel therapeutic strategies to improve their outcome.
In this Special Issue, original research articles and reviews are welcome. We look forward to receiving your contributions.
Dr. Alberto Pappo
Prof. Dr. Godfrey Chan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pediatric solid tumor
- brain tumors
- therapeutic strategies
- immunotherapy
- targeted therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.